The Peptide Audit
← The Peptide Audit Weekly
Week of September 28, 2026

BPC-157: peptide of the week

0
Price drops
0
Back in stock
8
New lab results
Mostly animal & lab studies

What is BPC-157?

BPC-157 (“body protection compound”) is a synthetic 15-amino-acid peptide based on a fragment of a protein found in human gastric juice.

How it works

Laboratory studies suggest it interacts with growth-factor and nitric-oxide signaling involved in blood-vessel formation (angiogenesis) and tissue repair, though its exact receptor target has not been identified.

What researchers are studying

  • ●Tendon, ligament and muscle healing in rodents
  • ●Gastrointestinal lining and ulcer models
  • ●Blood-vessel growth in injury models

Where the evidence stands: Not approved by the FDA for any use. Human data are limited to a handful of small studies. Prohibited in sport by WADA.

Recent peer-reviewed research

  1. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
    The American journal of sports medicine · 2026 Jan · PubMed ↗
  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
    Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026 Jan 1 · PubMed ↗
  3. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
    Sports medicine (Auckland, N.Z.) · 2026 Aug · PubMed ↗
Read the full BPC-157 guide →

New lab results that week

Free weekly email
Get The Peptide Audit Weekly

Every Monday: the week's price drops and restocks, new third-party lab results, and a plain-English research guide with the latest studies. No spam — unsubscribe anytime.

Educational content only — not medical advice. Prices reflect the week of publication; see the Price Index for current prices. Compounds referenced are sold by third parties for laboratory research use only. The Peptide Audit.